As part of our continued policy work across the continent, Youth Cancer Europe recently participated as co-signatories of WECAN’s position paper on further EU integration of HTA (health technology assessment). The paper, which supports the European Commission’s legislative proposal for a regulation of the European Parliament and of the Council on health technology assessment and amending Directive 2011/24/EU, focuses on efforts to speed up the assessment process for new medicines and equitable access to new therapies, as well as proposing additional considerations for patient-centricity and patient engagement, transparency and accountability.

WECAN is an informal network of leaders of European cancer patient umbrella organisations, of which YCE is a member.

You can read and download the full paper, which was presented on 21 June 2018, on PDF here.

For more information about the WECAN network, please visit their website http://www.wecanadvocate.eu